CROs/Service Providers

Covance launches five-year collaboration on early clinical research

Friday, January 18, 2013 01:23 PM

Global CRO Covance and the Royal Liverpool and Broadgreen University Hospitals NHS Trust have entered into a five-year exclusive agreement to work together in conducting early clinical trials at the Royal Liverpool University Hospital on behalf of biotechnology and pharmaceutical companies.

More... »

InDevR spins off ViroCyt, raises growth capital

Wednesday, January 16, 2013 11:50 AM

ViroCyt, a privately held life science company, has begun operations after spinning off from InDevR, a developer of advanced life science instrumentation and assays. Concurrent with the formation of ViroCyt, funding was secured from a group of investors led by High Country Venture.

More... »

ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

More... »

Partners HealthCare, Illumina announce founding members of GeneInsight Network

Monday, January 14, 2013 02:49 PM

Partners HealthCare, a Boston-based integrated health system, and Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, announced the GeneInsight-Illumina Founding Network Members, including the ARUP Laboratories, Mount Sinai Genetic Testing Laboratory, New York Genome Center (NYGC), Partners HealthCare and Illumina.

More... »

Almac doubles drug development capacity with a new non-GMP facility

Monday, January 14, 2013 10:11 AM

Global service provider Almac has expanded its drug product pharmaceutical development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at its U.K. headquarters in Craigavon.

More... »

Cerner, Icon partner to streamline late-phase research studies

Monday, January 14, 2013 09:14 AM

Cerner, a global innovator in electronic health record (EHR) and research technology, and global CRO Icon have formed an agreement to provide pharmaceutical and device sponsors with late-phase research technology to streamline the collection of information related to the safety, effectiveness and value of their medical products.

More... »

PAREXEL chairman and CEO Josef von Rickenbach elected 2013 ACRO chairman

Thursday, January 10, 2013 02:18 PM

PAREXEL International chairman and CEO, Josef von Rickenbach, has been named 2013 chairman of the Association of Clinical Research Organizations (ACRO).

More... »

Almac, TTP Labtech form alliance in fluorescence lifetime technology

Monday, January 7, 2013 11:53 AM

Global service provider Almac and TTP Labtech, a global developer and manufacturer of laboratory equipment, have formed an alliance in the field of fluorescence lifetime (FLT) technology to provide class leading screening performance. This will give customers of either party access to a broad range of biological applications coupled with the next generation of microplate reader technology.

More... »

WCCT Global, Verified Clinical Trials enhance clinical trials database registry

Monday, January 7, 2013 11:24 AM

WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help them enhance the capabilities of the VCT Clinical Trials Database Registry system.

More... »

Illumina strengthens reproductive health segment with acquisition of Verinata Health

Monday, January 7, 2013 10:26 AM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, has signed a definitive agreement to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million, plus up to $100 million in milestone payments through 2015.

More... »